London woman off insulin for Type 1 diabetes after a single dose of experimental manufactured stem cells

But there’s a tradeoff. The patients, however, require immune-suppressing drugs for life, so that the immune system doesn’t destroy the cells.

The 36-year-old nurse and mother is part of a small, but what some call “milestone study,” of patients with Type 1 Diabetes using manufactured stem cells, designed to grow in the liver and become the full array of pancreatic islet cells that naturally control blood sugar levels.